MEDIVATION INC. MDVN (NASDAQ)

$ 15.41
11/18/2008 20:09
Sponsored by
Click here!
Change: unch (unch%)
Volume: 223,501

Avg. Volume: 332350
P/E Ratio: 0
EPS (Annual): -1.86
Profit Margin:
Dividend & Yield(Annual): 0%
Shares Outstanding: 30,000
Institutional Shareholders: 98.48%
Last: 15.41
Change: unch (unch%)
Prev. Close: 15.41
Open: 16.05
Day's Range: 15.00 - 16.83
52wk Range: 11.53 - 34.40
Market Value: 478,880
Beta:
12-month EPS Change: 0.00%
Total Return Last 12 Months: -17.06%
Total Return Last 3 Years: -12.06%
Total Return Last 5 Years: -12.69%
5-Year Revenue Growth Rate: 0.00%
5-Year Dividend Growth Rate: 0.00%
5-Year EPS Growth Rate: 0.00%


Headlines on MDVN

Movers roundup: General Motors, Chesapeake Energy

Among the stock activity stories for Tuesday, Nov. 11, from AP Financial News: NEW YORK (AP)--Shares of General Motors Corp. plunged to their lowest price since the days of World W...READ MORE
Nov 11, 2008 3:04PM
Keywords: GM, CHK, MDVN, VPHM, OPTR, NTAP

Medivation shares fall on new Dimebon timeline

(NEW YORK)Shares of biotechnology company Medivation Inc. fell Tuesday as the market reacted to an extended timeline for the development program on the lead drug candidate Dimebon.READ MORE
Nov 11, 2008 11:44AM
Keywords: MDVN, PFE

Medivation deal with Pfizer clears review period

(SAN FRANCISCO)Medivation Inc. said Wednesday a partnership with Pfizer Inc. to develop a potential treatment for Alzheimer's disease and Huntington's disease has cleared a regulatory review.READ MORE
Oct 22, 2008 8:03AM
Keywords: MDVN, PFE

Medivation jumps to all-time high on Pfizer pact

(NEW YORK)Shares of Medivation Inc. climbed to an all-time high Wednesday after the company struck a marketing agreement with Pfizer Inc. for the Alzheimer's disease and Huntington's disease...READ MORE
Sep 03, 2008 5:23PM
Keywords: MDVN, PFE

Movers roundup: Forest Labs, Continental

Among the stock activity stories for Wednesday, Sept. 3, from AP Financial News: NEW YORK (AP)--Shares of Forest Laboratories Inc. fell to a seven-year low Wednesday following disa...READ MORE
Sep 03, 2008 2:30PM
Keywords: FRX, CAL, MDVN, PFE, ZUMZ

Pfizer and Medivation to partner on Dimebon

(NEW YORK)Pfizer Inc. and Medivation Inc. on Wednesday entered a partnership to develop and promote Medivation's Dimebon, a drug candidate designed to treat Alzheimer's disease and Huntingto...READ MORE
Sep 03, 2008 8:55AM
Keywords: PFE, MDVN

Medivation shares fall on wider-than-expected loss

(NEW YORK)Shares of biotechnology company Medivation Inc. fell Tuesday after the company reported a wider-than-expected loss, as research and development expenses continue rising.READ MORE
Aug 12, 2008 7:21PM
Keywords: MDVN
RSS Page | Sign up for Google Alerts


Data Provided By Barchart.com
advertisement

Top Competitors

AMGEN INC. +9.80 56.34
GILEAD SCIENCES -3.90 45.22
CELGENE CORPORA -10.10 57.57
STEMCELLS INC. -61.50 1.13
BIOGEN IDEC INC -30.40 43.80